AI assistant
Inogen Inc — Director's Dealing 2022
Mar 4, 2022
33625_dirs_2022-03-03_2f55b4cd-1e10-4199-a3b9-78d8ddf419a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2022-03-01
Reporting Person: Sanford Bart Ben (EVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-01 | Common Stock | A | 1635 | $0.00 | Acquired | 6514 | Direct |
| 2022-03-01 | Common Stock | F | 644 | $35.21 | Disposed | 5870 | Direct |
| 2022-03-01 | Common Stock | A | 2184 | $0.00 | Acquired | 8054 | Direct |
| 2022-03-01 | Common Stock | F | 911 | $35.21 | Disposed | 7143 | Direct |
| 2022-03-01 | Common Stock | A | 1881 | $0.00 | Acquired | 9024 | Direct |
| 2022-03-01 | Common Stock | F | 737 | $35.21 | Disposed | 8287 | Direct |
| 2022-03-01 | Common Stock | M | 1214 | $0.00 | Acquired | 9501 | Direct |
| 2022-03-01 | Common Stock | F | 675 | $35.21 | Disposed | 8826 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | Restricted Stock Unit | $ | M | 273 | Disposed | Common Stock (273) | Direct | |
| 2022-03-01 | Restricted Stock Unit | $ | M | 941 | Disposed | Common Stock (941) | Direct | |
| 2022-03-01 | Restricted Stock Unit | $ | A | 5680 | Acquired | Common Stock (5680) | Direct |
Footnotes
F1: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on March 1, 2019.
F2: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2019 performance-based restricted stock award granted on March 1, 2019 and vested on March 1, 2022.
F3: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 1, 2020.
F4: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2020 performance-based restricted stock award granted on March 1, 2020 and vested on March 1, 2022.
F5: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on March 1, 2021.
F6: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2021 performance-based restricted stock award granted on March 1, 2021 and vested on March 1, 2022.
F7: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2022.
F8: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F9: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.
F10: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.
F11: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.